GenMark Diagnostics (GNMK) Posts Q2 Loss of 39c, Narrower than Views
Tweet
Share
E-mailGet Alerts GNMK Hot Sheet
Join SI Premium – FREE
GenMark Diagnostics (NASDAQ: GNMK) reported Q2 EPS of ($0.39), $0.14 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $901 thousand versus the consensus estimate of $860 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- Precision Optics Corporation, Inc. (POCI) Reports Q4 Loss of $0.01
- IDT Corp. (IDT) Misses Q4 EPS by 3c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
